The Impella device is a type of mechanical circulatory support (MCS) that helps patients with severe heart failure by providing temporary support to the heart. It is often used as a bridge to heart transplant in patients who are too unstable to wait for a transplant without mechanical support. This device temporarily takes over the work of the heart, ensuring that blood is pumped effectively throughout the body while the patient awaits a donor heart.

The Impella device is a percutaneous ventricular assist device (VAD) that can be inserted into the heart via a catheter, making it minimally invasive compared to other mechanical support systems. It is commonly used in patients who have cardiogenic shock or acute decompensated heart failure, as it helps stabilize them long enough to receive a heart transplant or recover sufficiently for a potential recovery without needing a transplant.

What is the Impella Device?

The Impella device is a small, catheter-based mechanical pump that provides temporary circulatory support by assisting the heart in pumping blood. The device is inserted through the femoral artery or other peripheral access sites and positioned within the left ventricle of the heart.

• Impella 2.5: Provides a flow of up to 2.5 liters per minute.
• Impella 5.0: Provides a flow of up to 5 liters per minute.
• Impella CP: A version of the device that provides support to circulatory function with higher flow rates than the Impella 2.5.

How Impella Works

The Impella device works by drawing blood from the left ventricle, pumping it through the device's motor, and then delivering it into the ascending aorta. This direct support helps to maintain blood flow to vital organs like the brain, kidneys, and liver, especially in patients whose hearts are no longer able to pump blood effectively due to acute heart failure or cardiogenic shock.

Indications for Impella as a Bridge to Heart Transplant

The Impella device is typically used in patients with severe heart failure or cardiogenic shock who are not eligible for heart transplant or who are waiting for a heart transplant but are hemodynamically unstable. Common indications for the use of Impella as a bridge to heart transplant include:

1. Cardiogenic Shock:
• Patients with cardiogenic shock, where the heart is unable to pump enough blood to meet the body's needs, are at high risk for organ failure and death. The Impella device can provide life-saving support by helping the heart pump blood effectively until a donor heart is available.
2. Acute Decompensated Heart Failure:
• In patients with acute decompensated heart failure, where the heart suddenly becomes unable to maintain adequate circulation, the Impella can help maintain blood flow while awaiting heart transplantation.
3. End-Stage Heart Failure:
• For patients with end-stage heart failure who are waiting for a heart transplant, Impella offers an option for short-term mechanical circulatory support to bridge them to transplantation.
4. Post-Surgical Heart Failure:
• Patients who have undergone heart surgery (e.g., coronary artery bypass grafting, heart valve surgery) and experience postoperative heart failure or complications such as left ventricular dysfunction may benefit from the Impella device while they await a heart transplant.
5. Severe Myocardial Infarction:
• Massive heart attacks or myocardial infarctions (MI) causing severe left ventricular dysfunction and shock may warrant the use of the Impella device as a temporary measure while awaiting heart transplantation.
6. Refractory Arrhythmias:
• Some patients who experience life-threatening arrhythmias in the context of heart failure or cardiac arrest may benefit from the Impella device while awaiting further treatment or heart transplantation.

How Impella Works as a Bridge to Heart Transplant

The Impella device serves as a bridge to heart transplant in patients who need time to stabilize before a transplant, particularly in those who are too ill to survive without mechanical circulatory support. The device works by:

1. Providing Hemodynamic Support:
• The Impella device helps to stabilize the patient by increasing cardiac output and ensuring that vital organs receive adequate blood flow (e.g., the brain, kidneys, and liver), even when the heart is severely impaired.
2. Improving Oxygen Delivery:
• By maintaining blood flow and oxygen delivery to critical organs, the Impella helps prevent further organ damage, which can improve the chances of a successful transplant once the donor heart becomes available.
3. Preventing Organ Dysfunction:
• As the heart fails, blood flow to vital organs is compromised. The Impella provides sufficient flow, protecting organs like the liver, lungs, and kidneys from ischemic injury caused by poor perfusion, thus improving overall prognosis for the patient.
4. Bridge to Recovery or Heart Transplant:
• While the Impella can help stabilize the patient, it can also provide support for heart recovery in cases of acute heart failure. In some instances, it can allow the heart to heal enough to avoid a transplant, but it is mainly used for those who require a heart transplant to survive.

Procedure for Impella Insertion

The procedure to insert the Impella device is minimally invasive and typically performed in a catheterization lab (Cath Lab) or operating room. Here's how the procedure typically works:

1. Access Site:
• A catheter is inserted into the femoral artery (usually) or another suitable vascular site. Local anesthesia is used to numb the area, and the patient is sedated.
2. Device Insertion:
• The catheter with the Impella device is guided into the left ventricle of the heart via the aortic valve.
3. Device Positioning:
• The device is positioned so that it can draw blood from the left ventricle and deliver it into the ascending aorta, bypassing the heart’s pumping action temporarily.
4. Activation:
• Once the Impella device is in place, it is activated, and it starts to pump blood, providing circulatory support for the patient.
5. Monitoring:
• The patient is closely monitored during and after the procedure, and adjustments to the device settings may be made depending on the patient's condition.

Benefits of Impella as a Bridge to Heart Transplant

1. Life-Saving Circulatory Support:
• The Impella provides vital circulatory support for patients in cardiogenic shock or acute decompensated heart failure, helping them survive until a heart transplant becomes available.
2. Minimally Invasive:
• Unlike other forms of circulatory support (e.g., ECMO, which requires a more invasive setup), the Impella device is minimally invasive, inserted via a catheter, and often requires a shorter recovery time.
3. Protects Vital Organs:
• By maintaining adequate blood flow to critical organs, the Impella helps prevent organ dysfunction (especially kidney and liver failure) that can result from inadequate perfusion during heart failure.
4. Improved Transplant Outcomes:
• By improving the patient's stability and organ function, the Impella can enhance their overall suitability for heart transplant and improve outcomes after transplant surgery.
5. Bridge to Recovery:
• While primarily used as a bridge to heart transplant, in some cases, patients may experience enough cardiac recovery to potentially avoid the need for a transplant.

Risks and Complications of Impella Use

While the Impella device provides vital support, it carries certain risks and complications:

1. Bleeding:
• The insertion of the catheter can lead to bleeding complications, especially at the insertion site or internally.
2. Infection:
• Any invasive device carries the risk of infection, including potential infections at the catheter insertion site or in the bloodstream.
3. Vascular Complications:
• The insertion of the device through the femoral artery or another large blood vessel can lead to vascular injury, including arterial dissection or thrombosis (blood clots).
4. Hemolysis:
• The mechanical pumping action of the Impella can sometimes cause damage to red blood cells, leading to hemolysis (destruction of red blood cells) and anemia.
5. Device Malfunction:
• In rare cases, the Impella device may experience malfunction, which would require immediate intervention to replace or reposition the device.
6. Risk of Stroke:
• As with any device that manipulates blood flow, there is a risk of embolism, where blood clots may dislodge and cause a stroke.
7. Kidney Injury:
• Due to changes in blood flow and circulation, some patients may experience acute kidney injury while on the Impella device.

Post-Impella and Heart Transplant Surgery

Once a donor heart becomes available, the patient will undergo heart transplant surgery. The Impella device will be removed prior to or during the transplant procedure. After the transplant, the patient will be closely monitored for rejection, infection, and other complications. The patient will also be started on immunosuppressive therapy to prevent organ rejection.

• Recovery: Following heart transplant surgery, patients usually require cardiac rehabilitation to regain strength and improve heart function.

Prognosis and Survival Rates

The use of the Impella device as a bridge to heart transplant has significantly improved survival rates for patients with acute heart failure or cardiogenic shock awaiting transplant. Some studies suggest that:

• Survival rates to heart transplant with Impella support are generally 80-90% in patients without major complications.
• The one-year survival rate after heart transplant for patients who were supported by Impella is comparable to or better than that of patients who receive heart transplants without mechanical circulatory support.

Conclusion

The Impella device is an important tool for providing temporary circulatory support in patients with severe heart failure or cardiogenic shock awaiting a heart transplant. It offers life-saving benefits by maintaining blood flow and oxygenation to vital organs, buying crucial time until a donor heart becomes available. While the device has several advantages, it also carries risks that must be carefully managed. For many patients, it serves as an effective bridge to heart transplant, improving survival chances and outcomes.